NewsRx Logo Login/Signup
Home Newsletters Products Library About Us Contact -- Search NewsRx

NewsRx | Free Trials
Advertisement
VerticalNews | Global Warming
NewsRx | Free Newsletters
 
----------
------------
NewsRx on Facebook
-----
NewsRx Passes
Press Release Submissions
PR Login
-----
2008 Award Logo
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
-----
Google 2009 PageRank: #2 Among Top Health News and Media Publications
Google 2009 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2009 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2009 PageRank: #2 News and Media Site for the Pharmaceutical Industry
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
verify here.

Security by Verisign

Search Results for Adams Respiratory Therapeutics Inc


Filter Articles: Clinical News | Consumer News | Business News | All News | More Options

Results 1 - 20      Next >


Refine Search
Display Mode: Context | Summary
Fondation Ipsen: 5th Colloque Medecine et Recherche of the Cancer series: “Molecular Targets of Cancer Therapy”
2009 APR 6 ... winners for Medicine, the leading experts invited to present their works were: Julian Adams (Infinity Pharmaceuticals Inc., Cambridge, USA), James Allison (Memorial Sloan-Kettering ... Oncology, Pharmaceuticals, Protein Kinase Inhibitor, Proteins, Proteomics, Pulmonology, Respiratory Infection, Therapy, Treatment, Tyrosine Kinase, Fondation Ipsen. This ... the output published in a report after the event. This year’s topic focused on targeted therapeutics for cancer, which offer the promise of rational drug design based on mechanisms ...
Subject: Fondation Ipsen
Price: $3.00
*
Researchers from National Defense Medical College, Medical College describe findings in angiotensins
2009 JUN 29 ... at day 0 and 2, and the cell numbers were counted using a Neubauer haemocytometer (Clay-Adams, Parsippany, NJ, USA). The cell proliferation rates at day 2 were calculated in ... Cytokines, Fibrosis, Hepatology, Infectious Disease, Pharmaceuticals, Pulmonology, Respiratory Infection, Therapy, Treatment, National Defense Medical College, Medical College. ... blocker, candesartan," scientists writing in the Journal of Clinical Pharmacy and Therapeutics report. "Normal human adult lung fibroblasts were cultured. Candesartan ... of Clinical Pharmacy and Therapeutics can be contacted at: Wiley-Blackwell Publishing, Inc., Commerce Place, 350 Main St., Malden 02148, MA, USA. Keywords: Japan, ...
Subject: Angiotensins
Price: $3.00
*
Studies in the area of pulmonary embolism reported from University of Maryland
2010 FEB 1 ... additional information, contact J. Menaker, University of Maryland, Medical Center, R Adams Cowley Shock Trauma Center, Dept. of Surgery, Division Trauma Critical Care, Program ... Care Medicine, Diagnostics, Pulmonary Embolism This article was prepared by Respiratory Therapeutics Week editors from staff and other reports. Copyright 2010, Respiratory ...
Subject: Pulmonary Embolism
Price: $3.00
*
Xanodyne Announces New Executive Team Members
2009 JUL 27 ... as Vice President, Finance. Previously, she was Chief Financial Officer and Treasurer at Adams Respiratory Therapeutics. With nearly 20 years of finance and accounting experience in ... Xanodyne Pharmaceuticals, Inc., an integrated specialty pharmaceutical company with both development and commercial ...
Subject: Pharmaceuticals
Price: $3.00
*
Xanodyne Announces New President/CEO and Completes $38 Million Equity Financing
2009 JUN 15 ... Union Springs. Mr. Valentino most recently served as President and CEO, Adams Respiratory Therapeutics (NASDAQ:ARXT) and has over 30 years of experience in the ... Xanodyne Pharmaceuticals, Inc. is pleased to announce that Michael J. Valentino has been named to the position of ...
Subject: Pharmaceuticals
Price: $3.00
*
Acquisition of Adams Respiratory Therapeutics by Reckitt Benckiser
2007 DEC 24 ... Reckitt Benckiser Group plc (RB.L) ("Reckitt Benckiser") and Adams Respiratory Therapeutics (NASDAQ:ARxT) ("Adams") announce that they have entered into ... year ending June 2007 was $48m. Keywords: Adams Respiratory Therapeutics, Inc., Mergers and Acquisitions, Therapy, Treatment, Pharmaceuticals This ...
Subject: Adams Respiratory Therapeutics, Inc.
Price: $3.00
*
MiddleBrook Pharmaceuticals Announces $100 Million Investment to Support Launch of MOXATAG(TM)
2008 JUL 14 ... recently, Mr. Thievon was Executive Vice President, Sales and Corporate Accounts for Adams Respiratory Therapeutics (Adams). While with Adams, Mr. Thievon launched the Mucinex(R) ... MiddleBrook Pharmaceuticals, Inc. (NASDAQ:MBRK), a pharmaceutical company focused on developing and commercializing novel ...
Subject: MiddleBrook Pharmaceuticals, Inc.
Price: $3.00
*
MiddleBrook Pharmaceuticals Announces Changes to Management Team
2008 OCT 20 ... to joining MiddleBrook, Miller served as Vice President, Sales Operations & Training at Adams Respiratory Therapeutics, Inc. (Adams). Previously, he held numerous key positions in ...
Subject: Allergies
Price: $3.00
*
MonoSol Rx Completes Thin Film Ondansetron Pilot Bioequivalence Study
2008 MAR 3 ... This agreement would build upon the development and supply agreement that we signed with Adams Respiratory Therapeutics in March 2007 for another, as-yet-unnamed prescription ...
Subject: Vomiting
Price: $3.00
*
Reckitt Benckiser Announces Completion of Cash Tender Offer for All Outstanding Shares of Adams Respiratory Therapeutics, Inc.
2008 FEB 4 ... offer (the "Offer") for all outstanding shares of common stock (the "Shares") of Adams Respiratory Therapeutics, Inc. (NASDAQ:ARxT) ("Adams"). The Offer expired, as ...
Subject: Adams Respiratory Therapeutics, Inc.
Price: $3.00
*
Reckitt Benckiser Commences Cash Tender Offer for All Outstanding Shares of Adams Respiratory Therapeutics
2007 DEC 31 ... announced cash tender offer (the "Offer") for all of the outstanding shares of Adams Respiratory Therapeutics, Inc. (NASDAQ:ARxT) ("Adams"). As announced on ...
Subject: Reckitt Benckiser Group plc
Price: $3.00
*
Reckitt Benckiser Completes Acquisition of Adams Respiratory Therapeutics, Inc.
2008 FEB 11 ... (RB.L) ("Reckitt Benckiser") announced the successful completion of its acquisition of Adams Respiratory Therapeutics, Inc. (NASDAQ:ARxT) ("Adams") through a cash tender offer ...
Subject: Reckitt Benckiser
Price: $3.00
*
Reckitt Benckiser Receives Hart-Scott-Rodino Antitrust Clearance for Acquisition of Adams Respiratory Therapeutics
2008 JAN 21 ... Reckitt Benckiser Group plc (RB.L) ("Reckitt Benckiser") and Adams Respiratory Therapeutics, Inc. (NASDAQ:ARxT) ("Adams") announced that they have ...
Subject: Adams Respiratory Therapeutics, Inc.
Price: $3.00
*
Research and Markets: In November 2007, the NHS in the United Kingdom Announced That a Budget Undershoot for 2007/2008 of GBP1.8bn (US$3.72bn) Was Expected
2008 MAR 17 ... Benckiser has increased its presence in the OTC sector with the purchase of US company Adams Respiratory Therapeutics (Adams). Meanwhile, the UK takes fourth place in ...
Subject: Research and Markets Ltd.
Price: $3.00
*
Research data from M.S. Volpe and colleagues update understanding of respiratory medicine
2008 DEC 8 ... Care, 2008;53(10):1287-1294). For more information, contact A.B. Adams, Regions Hospital, Dept. of Critical Care & Pulmology Medical, 640 Jackson St., St. ... mechanical ventilation." Volpe and colleagues published their study in Respiratory Care (Ventilation Patterns Influence Airway Secretion Movement. Respiratory Care, ... Care, Respiratory Medicine. This article was prepared by Respiratory Therapeutics Week editors from staff and other reports. Copyright 2008, Respiratory Therapeutics ... Publisher contact information for the journal Respiratory Care is: Daedalus Enterprises Inc., 9425 N Mac Arthur Blvd., Ste. 100, Irving, TX 75063-4706, USA. ...
Subject: Respiratory Medicine
Price: $3.00
*
Schering-Plough Appoints Janet M. Barth Vice President, Investor Relations
2008 JUN 9 ... served as senior vice president, investor relations and corporate communications, for Adams Respiratory Therapeutics, which was a newly public specialty pharmaceutical company. In ...
Subject: Schering-Plough Corporation
Price: $3.00
*
United States Pharmaceuticals and Healthcare Report Q2 2008 is out Now
2008 APR 21 ... FDI. Over the past quarter a number of US assets have been snapped up with OTC firm Adams Respiratory Therapeutics being bought by UK-based Reckitt Benckiser. Japanese drugmaker ...
Subject: Research and Markets
Price: $3.00
*

Results 1 - 20      Next >




-----------------------
PR Login